We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+0.24%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.6B
AUM Growth
+$1.47B
Cap. Flow
+$1.6B
Cap. Flow %
9.12%
Top 10 Hldgs %
17.57%
Holding
1,695
New
602
Increased
310
Reduced
364
Closed
414

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$207M
2
PFE icon
Pfizer
PFE
+$171M
3
JNJ icon
Johnson & Johnson
JNJ
+$140M
4
SSNC icon
SS&C Technologies
SSNC
+$132M
5
MSFT icon
Microsoft
MSFT
+$131M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$158M
2
META icon
Meta Platforms (Facebook)
META
+$120M
3
BKNG icon
Booking.com
BKNG
+$106M
4
MRK icon
Merck
MRK
+$93.9M
5
IDXX icon
Idexx Laboratories
IDXX
+$92.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.54%
2 Technology 21.21%
3 Consumer Discretionary 13.38%
4 Industrials 12.45%
5 Financials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GEF icon
301
Greif
GEF
$5.04B
$7.05M 0.04%
186,026
-45,765
-20% -$1.6M
DD icon
302
DuPont de Nemours
DD
$19.2B
$7.04M 0.04%
78,586
-75,929
-49% -$6.69M
HZNP
303
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$7.02M 0.04%
257,699
+87,277
+51% +$2.26M
LNC icon
304
Lincoln National
LNC
$8.81B
$7.01M 0.04%
+116,162
New +$6.95M
FE icon
305
FirstEnergy
FE
$27.5B
$7M 0.04%
145,096
-70,638
-33% -$3.2M
DNKN
306
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$6.99M 0.04%
88,051
+72,358
+461% +$5.88M
IONS icon
307
Ionis Pharmaceuticals
IONS
$9.4B
$6.94M 0.04%
+115,771
New +$7.55M
TJX icon
308
TJX Companies
TJX
$178B
$6.93M 0.04%
124,259
+66,959
+117% +$3.65M
VMC icon
309
Vulcan Materials
VMC
$36.9B
$6.91M 0.04%
45,694
-244,125
-84% -$34.5M
ACN icon
310
Accenture
ACN
$108B
$6.78M 0.04%
35,229
+5,885
+20% +$1.14M
AVTA
311
DELISTED
Avantax, Inc. Common Stock
AVTA
$6.77M 0.04%
313,033
+231,303
+283% +$5.83M
CBRE icon
312
CBRE Group
CBRE
$42.9B
$6.76M 0.04%
127,445
-28,677
-18% -$1.51M
STC icon
313
Stewart Information Services
STC
$2.08B
$6.75M 0.04%
173,968
+144,358
+488% +$5.38M
BMY icon
314
Bristol-Myers Squibb
BMY
$132B
$6.71M 0.04%
132,426
-5,804
-4% -$273K
CCOI icon
315
Cogent Communications
CCOI
$508M
$6.69M 0.04%
121,360
+112,927
+1,339% +$6.73M
Z icon
316
Zillow
Z
$7.56B
$6.69M 0.04%
+224,205
New +$8.93M
EWBC icon
317
East-West Bancorp
EWBC
$18B
$6.68M 0.04%
150,822
-14,293
-9% -$628K
AXS icon
318
AXIS Capital
AXS
$7.55B
$6.65M 0.04%
+99,621
New +$6.29M
PII icon
319
Polaris
PII
$4.07B
$6.58M 0.04%
74,739
-2,392
-3% -$207K
EQNR icon
320
Equinor
EQNR
$92.4B
$6.52M 0.04%
343,994
-65,663
-16% -$1.21M
AIN icon
321
Albany International
AIN
$1.78B
$6.5M 0.04%
72,125
-49,334
-41% -$4.09M
RJF icon
322
Raymond James Financial
RJF
$34B
$6.48M 0.04%
117,932
+36,048
+44% +$1.96M
TENB icon
323
Tenable Holdings
TENB
$4.01B
$6.44M 0.04%
287,967
+19,589
+7% +$497K
CHD icon
324
Church & Dwight Co
CHD
$24.5B
$6.4M 0.04%
85,042
+72,253
+565% +$5.47M
TSCO icon
325
Tractor Supply
TSCO
$18B
$6.32M 0.04%
349,675
-7,810
-2% -$162K
11 12
13
14 15

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2019 Portfolio in Review

As of Q3 2019, Marshall Wace North America held 1,695 positions worth $17.6B, up 9.1% from $16.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace North America deployed $1.6B of net new capital in Q3 2019, opening 602 new positions and adding to 310 existing holdings. Its largest new stake was Johnson & Johnson: 1,065,531 shares worth $138M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $120M trimmed.

  • Marshall Wace North America's largest Q3 2019 buy was Johnson & Johnson: 1,065,531 shares worth $138M.
  • Marshall Wace North America added most to Apple in Q3 2019, an estimated $207M increase.
  • Marshall Wace North America's biggest Q3 2019 reduction was Meta Platforms (Facebook), cutting an estimated $120M.
  • Marshall Wace North America fully exited Abbott in Q3 2019, selling an estimated $158M.
  • Marshall Wace North America's ten largest holdings make up 18% of its $17.6B portfolio in Q3 2019.
  • Marshall Wace North America opened 602 new positions and closed 414 in Q3 2019.
  • Marshall Wace North America's portfolio value rose 9.1% quarter-over-quarter to $17.6B.

Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.